Answers are grounded in this paper and cite their sources.
The use of echinocandins for the treatment of invasive zygomycosis (IZ) is controversial since they show no activity in vitro. Although posaconazole shows promising results, the mortality rates of patients with IZ treated with posaconazole, at 30%, remain unacceptably high. The use of new therapies
No takes yet. Share an insight, caveat, or question.
Guembe et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: